SCHEMBL7267419

SCHEMBL7267419

COc1ccc(-c2cc(OC)c(OC)cc2CCN2CCN(c3cccc(Cl)c3C)CC2)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ HTR7 P34969 5/20 0.48
▸ MAPT P10636 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ ADRA1D P25100 2/20 0.45
▸ ADRA1A P35348 2/20 0.45
▸ ADRA1B P35368 2/20 0.45
▸ DRD2 P14416 6/20 0.44
▸ DRD4 P21917 5/20 0.44
▸ DRD3 P35462 5/20 0.44
▸ HTR1A P08908 4/20 0.43
▸ HTR2A P28223 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7268521 0.91 ADRA1D (0.50) HTR7MAPTKDM4EALDH1A1ALOX15
SCHEMBL8723945 0.85 ADRA1D (0.59) KDM4EADRA1DADRA1AADRA1BDRD2
SCHEMBL9405381 0.82 MEN1 (0.48) HTR7MAPTKDM4ETSHR
SCHEMBL7268609 0.80 HTR7 (0.46) HTR7MAPTKDM4EALDH1A1ALOX15
SCHEMBL7267422 0.76 HTR7 (0.42) HTR7MAPTKDM4EALDH1A1ALOX15
Mefeclorazine SCHEMBL2110367 0.74 ADRA1D (0.73) KDM4EALDH1A1ADRA1DADRA1AADRA1B
SCHEMBL7269688 0.72 KDM4E (0.52) HTR7KDM4EALDH1A1ALOX15TSHR
SCHEMBL2785351 0.72 DRD2 (0.54) KDM4EALDH1A1DRD2DRD3HTR1A
SCHEMBL2783222 0.70 DRD2 (0.75) KDM4EALDH1A1DRD2DRD4DRD3
SCHEMBL27410454 0.70 MEN1 (0.46) HTR7MAPTKDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0624584-B1 Piperazine derivatives useful as calmodulin inhibitors DAIICHI SEIYAKU CO (JP) 1998-08-19 — — EP claimed
US-6596706-B1 For the treatment of circulatory diseases cerebral diseases DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-07-22 — — US disclosed
EP-1029872-A1 PIPERAZINE-CYCLODEXTRIN COMPLEXES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2000-08-23 — — EP disclosed
EP-0624584-B1 Piperazine derivatives useful as calmodulin inhibitors DAIICHI SEIYAKU CO (JP) 1998-08-19 — — EP disclosed
EP-0624584-A1 Piperazine derivatives useful as calmodolin inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1994-11-17 — — EP disclosed
Send feedback